Mike Patterson

1.5k total citations
20 papers, 1.1k citations indexed

About

Mike Patterson is a scholar working on Surgery, Epidemiology and Infectious Diseases. According to data from OpenAlex, Mike Patterson has authored 20 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 6 papers in Epidemiology and 4 papers in Infectious Diseases. Recurrent topics in Mike Patterson's work include Tuberculosis Research and Epidemiology (4 papers), Infectious Diseases and Tuberculosis (4 papers) and Pregnancy-related medical research (3 papers). Mike Patterson is often cited by papers focused on Tuberculosis Research and Epidemiology (4 papers), Infectious Diseases and Tuberculosis (4 papers) and Pregnancy-related medical research (3 papers). Mike Patterson collaborates with scholars based in United Kingdom, United States and Canada. Mike Patterson's co-authors include Mohammad A. Ghatei, Stephen R. Bloom, Gary Frost, Rachel L. Batterham, Mark A. Cohen, Sylvia Ellis, Carel W. le Roux, Jeffrey M. Isner, Laurence H. Kedes and Ernst R. Schwarz and has published in prestigious journals such as Journal of the American College of Cardiology, The Journal of Clinical Endocrinology & Metabolism and The Journal of Physiology.

In The Last Decade

Mike Patterson

20 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mike Patterson United Kingdom 12 385 260 249 239 217 20 1.1k
Thuy Trang Nguyen Germany 15 204 0.5× 178 0.7× 280 1.1× 88 0.4× 163 0.8× 27 1.0k
Diana Takahashi United States 24 196 0.5× 360 1.4× 524 2.1× 95 0.4× 620 2.9× 58 1.8k
Galia Gat‐Yablonski Israel 22 210 0.5× 341 1.3× 382 1.5× 127 0.5× 130 0.6× 66 1.4k
Pierre Poitras Canada 22 164 0.4× 433 1.7× 139 0.6× 502 2.1× 63 0.3× 51 1.8k
P C Sizonenko Switzerland 13 290 0.8× 278 1.1× 220 0.9× 84 0.4× 128 0.6× 35 1.3k
Sinan Çağlayan Türkiye 14 599 1.6× 394 1.5× 128 0.5× 67 0.3× 76 0.4× 30 1.1k
Sarita Naik United States 11 187 0.5× 254 1.0× 161 0.6× 124 0.5× 58 0.3× 15 771
G. W. M. Millington United Kingdom 16 482 1.3× 237 0.9× 207 0.8× 84 0.4× 29 0.1× 42 1.2k
Raúl A. Bastarrachea United States 15 127 0.3× 213 0.8× 111 0.4× 109 0.5× 86 0.4× 55 663
W. F. Blum Germany 14 551 1.4× 362 1.4× 204 0.8× 51 0.2× 91 0.4× 23 1.3k

Countries citing papers authored by Mike Patterson

Since Specialization
Citations

This map shows the geographic impact of Mike Patterson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mike Patterson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mike Patterson more than expected).

Fields of papers citing papers by Mike Patterson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mike Patterson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mike Patterson. The network helps show where Mike Patterson may publish in the future.

Co-authorship network of co-authors of Mike Patterson

This figure shows the co-authorship network connecting the top 25 collaborators of Mike Patterson. A scholar is included among the top collaborators of Mike Patterson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mike Patterson. Mike Patterson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zwerling, Alice, et al.. (2024). Opportunities for tuberculosis elimination in the Canadian Arctic: cost-effectiveness of community-wide screening in a remote Arctic community. The Lancet Regional Health - Americas. 40. 100916–100916. 2 indexed citations
2.
Pease, Christopher, Gonzalo G. Alvarez, Ranjeeta Mallick, et al.. (2021). Cost-effectiveness analysis of 3 months of weekly rifapentine and isoniazid compared to isoniazid monotherapy in a Canadian arctic setting. BMJ Open. 11(5). e047514–e047514. 9 indexed citations
3.
Davies, Melanie J., Caroline Kristunas, Lisa Huddlestone, et al.. (2020). Increasing uptake of structured self-management education programmes for type 2 diabetes in a primary care setting: a feasibility study. Pilot and Feasibility Studies. 6(1). 71–71. 12 indexed citations
4.
Alvarez, Gonzalo G., Ranjeeta Mallick, Mike Patterson, et al.. (2020). The implementation of rifapentine and isoniazid (3HP) in two remote Arctic communities with a predominantly Inuit population, the Taima TB 3HP study. International Journal of Circumpolar Health. 79(1). 1758501–1758501. 9 indexed citations
5.
Pease, Christopher, Alice Zwerling, Ranjeeta Mallick, et al.. (2019). The latent tuberculosis infection cascade of care in Iqaluit, Nunavut, 2012–2016. BMC Infectious Diseases. 19(1). 890–890. 14 indexed citations
6.
7.
Gotsis, Marientina, et al.. (2016). Inner activity. 1–2. 3 indexed citations
8.
Ellis, Amy, Mike Patterson, Tanja Dudenbostel, David A. Calhoun, & Barbara A. Gower. (2015). Effects of 6-month supplementation with β-hydroxy-β-methylbutyrate, glutamine and arginine on vascular endothelial function of older adults. European Journal of Clinical Nutrition. 70(2). 269–273. 13 indexed citations
9.
Furness, John B., Billie Hunne, Lei Yin, et al.. (2011). Investigation of the presence of ghrelin in the central nervous system of the rat and mouse. Neuroscience. 193. 1–9. 96 indexed citations
10.
11.
McGowan, Barbara, Sarah A. Stanley, Mike Patterson, et al.. (2008). Relaxin-3 stimulates the hypothalamic-pituitary-gonadal axis. American Journal of Physiology-Endocrinology and Metabolism. 295(2). E278–E286. 70 indexed citations
12.
McGowan, Barbara, Sarah A. Stanley, N. E. White, et al.. (2006). Hypothalamic mapping of orexigenic action and Fos-like immunoreactivity following relaxin-3 administration in male Wistar rats. American Journal of Physiology-Endocrinology and Metabolism. 292(3). E913–E919. 55 indexed citations
13.
McGowan, Barbara, Sarah A. Stanley, K. L. Smith, et al.. (2006). Effects of acute and chronic relaxin-3 on food intake and energy expenditure in rats. Regulatory Peptides. 136(1-3). 72–77. 105 indexed citations
14.
Thakor, Avnesh S., M. Bloomfield, Mike Patterson, & Dino A. Giussani. (2005). Calcitonin gene‐related peptide antagonism attenuates the haemodynamic and glycaemic responses to acute hypoxaemia in the late gestation sheep fetus. The Journal of Physiology. 566(2). 587–597. 2 indexed citations
15.
Tan, Tricia, Mark Vanderpump, Bernard Khoo, et al.. (2004). Somatostatin Infusion Lowers Plasma Ghrelin without Reducing Appetite in Adults with Prader-Willi Syndrome. The Journal of Clinical Endocrinology & Metabolism. 89(8). 4162–4165. 97 indexed citations
16.
Batterham, Rachel L., Carel W. le Roux, Mark A. Cohen, et al.. (2003). Pancreatic Polypeptide Reduces Appetite and Food Intake in Humans. The Journal of Clinical Endocrinology & Metabolism. 88(8). 3989–3992. 367 indexed citations
17.
Schwarz, Ernst R., Mark Speakman, Mike Patterson, et al.. (2000). Evaluation of the effects of intramyocardial injection of DNA expressing vascular endothelial growth factor (VEGF) in a myocardial infarction model in the rat—angiogenesis and angioma formation. Journal of the American College of Cardiology. 35(5). 1323–1330. 218 indexed citations
18.
Patterson, Mike, et al.. (1995). The Effects of Practice Administrations in Learning to Administer and Score the WAIS-R: A Partial Replication. Educational and Psychological Measurement. 55(1). 32–37. 11 indexed citations
19.
Patterson, Mike, et al.. (1994). Pain relief following tennis elbow release.. PubMed. 39(1). 60–1. 9 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thuy Trang Nguyen Breakdown of academic impact, for papers by Diana Takahashi Breakdown of academic impact, for papers by Galia Gat‐Yablonski Breakdown of academic impact, for papers by Pierre Poitras Breakdown of academic impact, for papers by P C Sizonenko Breakdown of academic impact, for papers by Sinan Çağlayan Breakdown of academic impact, for papers by Sarita Naik Breakdown of academic impact, for papers by G. W. M. Millington Breakdown of academic impact, for papers by Raúl A. Bastarrachea Breakdown of academic impact, for papers by W. F. Blum
Rankless by CCL
2026